title: Prognostic implications of transient left ventricular cavitary dilation during exercise and dipyridamole-thallium imaging.
abstract: OBJECTIVE
  To determine the prognostic implication of exercise and dipyridamole-induced transient left ventricular cavitary dilation (TLVD).
  
  
  METHODS
  TLVD was observed and a follow-up obtained in 61 patients after exercise and in 62 patients following dipyridamole infusion.
  
  
  METHODS
  There was no statistical difference between groups in terms of sex, history of hypertension, diabetes, renal failure, previous myocardial infarction, severity of angina syndrome, congestive heart failure, resting electrocardiographic (ECG) abnormalities, clinical or ECG signs of ischemia during stress, number of reversible perfusion defects on thallium images or duration of follow-up (21 months).
  
  
  RESULTS
  Dipyridamole patients were slightly older (64 versus 57 years) and displayed more thallium redistribution (P = 0.002). After a mean follow-up of 21 months, both fatal and nonfatal (myocardial infarction or cardiac death) cardiac events were more frequent in the dipyridamole group (50% versus 9%, P = 0.0001).
  
  
  CONCLUSIONS
  Patients with dipyridamole-induced TLVD are at greater risk than those with exercise-induced TLVD at the authors' institution.
authors.affiliation: Maisonneuve-Rosemont Hospital, Montreal Heart Institute, Quebec.
authors.forename: M
authors.initials: M
authors.lastname: Veilleux
authors.forename: J
authors.initials: J
authors.lastname: Lette
authors.forename: A
authors.initials: A
authors.lastname: Mansur
authors.forename: C
authors.initials: C
authors.lastname: Bertrand
authors.forename: M
authors.initials: M
authors.lastname: Cerino
authors.forename: M
authors.initials: M
authors.lastname: Picard
authors.forename: D
authors.initials: D
authors.lastname: McNamara
authors.forename: M C
authors.initials: MC
authors.lastname: Eybalin
authors.forename: A
authors.initials: A
authors.lastname: Levasseur
authors.forename: S
authors.initials: S
authors.lastname: Nattel
mesh_terms: D000368:Aged; D015897:Comorbidity; D003327:Coronary Disease / Q000145:classification / Q000150:complications / Q000175:diagnosis* / Q000401:mortality*; D004176:Dipyridamole; D005080:Exercise Test; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000139:chemically induced* / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D013794:Thallium Radioisotopes
chemical_list: D013794:Thallium Radioisotopes; D004176:Dipyridamole